Expertise in
15
conditions

Bart Van Hoek

Leiden, ZH, NL 
Expertise in
15
conditions
Leiden, ZH, NL 

Overview

Bart Van Hoek practices practicing medicine in Leiden, Netherlands.

Mr. Van Hoek is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Autoimmune Hepatitis, Cholangitis, Sclerosing Cholangitis, Liver Transplant, and Hepato-Pancreato-Biliary Surgery.

He is actively involved in clinical research, co-authoring 172 peer reviewed articles and participating in 4 clinical trials.

Gender

Male

Locations

Leiden, ZH, Netherlands
Other Locations
Rotterdam, ZH, Netherlands
Netherlands
Utrecht, UT, Netherlands

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Placebo-Controlled, Multi-dose, Phase 2 Study to Determine the Safety, Tolerability and Pharmacodynamic Effect of Fazirsiran (TAK-999, ARO-AAT) in Patients With Alpha-1 Antitrypsin Deficiency (AATD) [SEQUOIA]
A Placebo-Controlled, Multi-dose, Phase 2 Study to Determine the Safety, Tolerability and Pharmacodynamic Effect of Fazirsiran (TAK-999, ARO-AAT) in Patients With Alpha-1 Antitrypsin Deficiency (AATD) [SEQUOIA]
Enrollment Status: Completed
Publish Date: November 04, 2025
Intervention Type: Other, Drug
Study Drug: ARO-AAT
Study Phase: Phase 2
A Randomised, Open-label Clinical Trial Assessing the Efficacy and Safety of Mycophenolate Mofetil Versus Azathioprine for Induction of Remission in Treatment Naive Autoimmune Hepatitis
A Randomised, Open-label Clinical Trial Assessing the Efficacy and Safety of Mycophenolate Mofetil Versus Azathioprine for Induction of Remission in Treatment Naive Autoimmune Hepatitis
Enrollment Status: Unknown
Publish Date: June 22, 2023
Intervention Type: Drug
Study Drugs: Mycophenolate mofetil, Azathioprine
Study Phase: Phase 4
A Multicenter Randomized in Primary Livertransplantation Comparing Longterm Renal Function in Recipients Treated With Tacrolimus Alone and Recipients Treated With a Combination Tacrolimus and Sirolimus
A Multicenter Randomized in Primary Livertransplantation Comparing Longterm Renal Function in Recipients Treated With Tacrolimus Alone and Recipients Treated With a Combination Tacrolimus and Sirolimus
Enrollment Status: Completed
Publish Date: March 18, 2022
Intervention Type: Drug
Study Phase: Phase 4
A Phase 2 Dose Ranging, Randomized, Double Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Biliary Cholangitis (PBC) With or Without an Inadequate Response to Ursodeoxycholic Acid (UDCA)
A Phase 2 Dose Ranging, Randomized, Double Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Biliary Cholangitis (PBC) With or Without an Inadequate Response to Ursodeoxycholic Acid (UDCA)
Enrollment Status: Completed
Publish Date: May 18, 2021
Intervention Type: Drug
Study Phase: Phase 2
View 3 Less Clinical Trials

172 Total Publications

Definition, diagnosis, and treatment of primary biliary cholangitis-autoimmune hepatitis (PBC-AIH) variant: An international expert Delphi consensus.
Definition, diagnosis, and treatment of primary biliary cholangitis-autoimmune hepatitis (PBC-AIH) variant: An international expert Delphi consensus.
Journal: Hepatology (Baltimore, Md.)
Published: November 19, 2025

Frequently Asked Questions about Bart Van Hoek

Is Bart Van Hoek a top-rated expert for Autoimmune Hepatitis?

MediFind is an objective health platform that identifies experts based on real-world data. Bart Van Hoek is classified as an Elite expert for Autoimmune Hepatitis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Bart Van Hoek participate in research or clinical trials?

Yes. Bart Van Hoek has published 172 articles and abstracts on conditions like Autoimmune Hepatitis. You can view a list of Bart Van Hoek's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Van Hoek's expertise for a condition
ConditionClose
View All 8 Advanced Conditions
View All 24 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile